1Perou CM,Sorlie T,Eisen MB,et al.Molecular portraits of human breast tumors[J].Nature,2000,406(6797):747-752.
2Van de Veer LJ,Dai H,Van de Vijver MJ,et al.Gene expression profiling predicts clinical outcome of breast cancer[J].Nature,2002,415(6871):530-536.
3Sotiriou C,Neo SY,McShane LM,et al.Breast cancer classification and prognosis based on gene expression profiles from a population based study[J].Proc Natl Acad Sci USA,2003,100(18):10393-10398.
4Rakha EA,El-Sayed ME,Green AR,et al.Prognostic markers in triple-negative breast cancer[J].Cancer,2007,109(1):25-32.
5Cleator S,Heller W,Coombes RC.Triple-negative breast cancer:therapeutic options[J].Lancet Oncol,2007,8(3):235-244.
6Chu KC,Lamar CA,Freeman HP.Racial disparities in breast carcinoma survival rates:separating factors that affect diagnosis from factors that affect treatment[J].Cancer,2003,97(11):2853-2860.
7Cunningham JE,Butler WM.Racial disparities in female breast cancer in South Carolina:clinical evidence for abiological basis[J].Breast Cancer Res Treat,2004,88(2):161-176.
8Carey LA,Perou CM,Livasy CA,et al.Race,breastcancer subtypes,and survival in the Carolina Breast Cancer Study[J].JAMA,2006,295(21):2492-2502.
9Nielsen TO,Hsu FD,Jensen K,et al.Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma[J].Clin Cancer Res,2004,10(16):5367-5374.
10Banerjee S,Reis-Filho JS,Ashley S,et al.Basal-like breast carcinomas:clinical outcome and response to chemotherapy[J].J Clin Pathol,2006,59(7):729-735.
8Bauer KR, Brown M, Cress RD, etal. Descriptive analysis of estro- genreceptor (ER) negative, progesterone receptor (PR) negative, and HER2-negative invasive breast cancer, the so-called triple-neg- ative phenotype : a population based study from the California cancer Registry[J]. Cancer,2007,109(9) :172.
